Literature DB >> 2080896

Chemotherapeutic agents, XVIII: Synthesis of pi-deficient pyrimidines and fused pyrimidines as leishmanicidal agents.

V J Ram1.   

Abstract

Synthesis of 6-aryl-5-cyano-2-thiouracils 1a-d from the condensation-cyclization of an aromatic aldehyde, thiourea and ethyl cyanoacetate has been described. Alkylation of 1a-d under different reaction conditions with mono- and dihalo-alkanes yielded 2, 3, and 6. Interaction of 1 with POCl3 provided halopyrimidines 8a,b. Nucleophilic substitution on 8 and 3 with aromatic amines gave 9a-d and 7a-d respectively. 6-Chloro-5-nitro-3-methyluracil (11) obtained by nitration of 10 underwent nucleophilic substitution with amines providing 12. Some of the compounds screened as leishmanicides did not exhibit any significant activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2080896     DOI: 10.1002/ardp.19903231103

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  3 in total

1.  Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibition.

Authors:  Zafer Sahin; Sevde Nur Biltekin; Leyla Yurttas; Barkin Berk; Yağmur Özhan; Hande Sipahi; Zhan-Guo Gao; Kenneth A Jacobson; Şeref Demirayak
Journal:  Eur J Med Chem       Date:  2020-12-31       Impact factor: 6.514

2.  4-Hy-droxy-6-(4-meth-oxy-phen-yl)-4-phenyl-1,3-diazinane-2-thione.

Authors:  H C Devarajegowda; K R Roopashree; Irfan Ali Mohammed; Ravish Sankolli
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-09

3.  Pyrimidine-5-carbonitrile based potential anticancer agents as apoptosis inducers through PI3K/AKT axis inhibition in leukaemia K562.

Authors:  Nehad M El-Dydamony; Rana M Abdelnaby; Rasha Abdelhady; Omaima Ali; Mohamed I Fahmy; Rasha R Fakhr Eldeen; Amira A Helwa
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.